RNAi as an antiviral therapy

Bibliography

• GOTTLIEB MS, SCHROFF R, SCHANKER HM et al.: Pneumocystis carinfi pneumonia and mucosal candidiasis in previously healthy homosexual men. N Engl. J. Med. (1981) 305:1425–1430.
   PubMed Web of Science ®Google Scholar
• CHEMANN JC, BANE-SINOUSSI F, DAUGUET C et al.: Isolation of a new retrovirus in a patient at risk for acquired immunodeficiency syndrome. Antibiot. Chemother. (1983) 3:48–53.
   Google Scholar
• COFFIN JM: Human immunodeficiency virus. Science (1986) 232:697.
   PubMed Web of Science ®Google Scholar
• POPOVIC M, SARNGADHARAN MG, READ E et al.: Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science (1984) 4648:497–500.
   Google Scholar
• HAHN BH, SHAW GM, ARYA SK et aL: Molecular cloning and characterization of the HTLV-III virus associated with AIDS. Nature (1984) 312:166–169.
   PubMed Web of Science ®Google Scholar
• SHAW GM, HAHN BH, ARYA SK et aL: Molecular characterization of human T-cell leukemia (lymphotropic) virus Type III in the acquired immune deficiency syndrome. Science (1984) 226:1165–1171.
   PubMed Web of Science ®Google Scholar
• HOGAN DR, SALOMAN JA: Prevention and treatment of human immunodeficiency virus/acquired immunodeficiency syndrome in resource-limited settings. Bull. World Health Organ. (2005) 2:135–143.
   Google Scholar
• TAKEB E Y, KUSAGAWA S, MOTOMURA K: Molecular epidemiology of HIV: tracking AIDS pandemic. Pediatr. Int. (2004) 2:236–244.
   Google Scholar
• THRONE C, NEWELL ML: Mother-to-child transmission of HIV infection and its prevention. Curr. HIV Res. (2003) 4:447–462.
   Google Scholar
• KASSAYE SG, KATZENSTEIN D: HIV/AIDS care and treatment in sub-Saharan Africa. AIDS Rev. (2003) 4:195–204.
   Google Scholar
• BAGASRA O, PRILLIMAN KR: RNA interference. J. Mot Histo/. (2004) 35:545–553.
   PubMedGoogle Scholar
• HAMILTON AJ, BAULCOMBE DC: A species of small antisense RNA in posttranscriptional gene silencing in plants. Science (1999) 286:950–952.
   PubMed Web of Science ®Google Scholar
• ••An excellent and pioneering finding onRNAi in plants.
   Google Scholar
• FIRE A: RNA-triggered gene silencing. Trends Genet. (1999) 15:358–363.
   PubMed Web of Science ®Google Scholar
• ••One of the very first reports on siRNAs.
   Google Scholar
• ZAMORE PD, TUSCHL T, SHARP PA et al.: RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell (2000) 101:25–33.
   PubMed Web of Science ®Google Scholar
• AMBROS V: MicroRNAs: tiny regulators with great potential. Cell (2001) 107:823–826.
   PubMed Web of Science ®Google Scholar
• •An early description of miRNA.
   Google Scholar
• MATTICK JS, MAKUNIN IV: Small regulatory RNAs in mammals. Hum. MoL Genet. (2005) 1:R121–132.
   Web of Science ®Google Scholar
• SCHWAB R, PALATNIK JF, RIESTER M et al.: Specific effects of microRNAs on the plant transcriptome. Dev. Cell (2005) 4:517–527.
   Google Scholar
• MOTAMEDI MR, VERDEL A, COLMENARES SU et al.: Two RNAi complexes, RITS and RDRC, physically interact and localize to noncoding centromeric RNAs. Cell (2004) 119:789–802.
   PubMed Web of Science ®Google Scholar
• TURELLI P, TRONO D: Editing at the crossroad of innate and adaptive immunity. Science (2005) 307:1061–1065.
   PubMed Web of Science ®Google Scholar
• NOLAN D, JAMES I, MALLAL S: HIV: experiencing the pressures of modern life. Science (2005) 307:1422–1424.
   PubMed Web of Science ®Google Scholar
• YANG W, WANG Q, HOWELL KL et aL: ADAR1 RNA deaminase limits short interfering RNA efficacy in mammalian cells. J. Biol. Chem. (2005) 280:3946–3953.
   PubMed Web of Science ®Google Scholar
• LEE Y, KIM M, HAN J et al.: MicroRNA genes are transcribed by RNA polymerase II. EMBO J. (2004) 20:4051–4060.
   Google Scholar
• WANG C, POLITZ JC, PEDERSON T, HUANG S: RNA polymerase III transcripts and the PTB protein are essential for the integrity of the perinucleolar compartment. MoL Biol. Cell (2003) 14:2425–2435.
   Google Scholar
• HERR AJ, JENSEN MB, DALMAY T et al.: RNA polymerase IV directs silencing of endogenous DNA. Science (2005) 5718:118–120.
   Google Scholar
• GUPTA BP, WANG M, STERNBERG PW: The C. elegans LIM homeobox gene lin-11 specifies multiple cell fates during vulval development. Development (2003) 12:2589–2601.
   Google Scholar
• ROGELJ B, GIESE KP: Expression and function of brain specific small RNAs. Rev. Neurosci. (2004) 3:185–198.
   Google Scholar
• BANDURA JL, BEALL EL, BELL M et al.:Humpty dumpty is required for developmental DNA amplification and cell proliferation in Drosophila. Curr. Biol. (2005) 8:755–759.
   Google Scholar
• TOMARI Y, ZAMORE PD. Perspective: machines for RNAi. Genes Dev. (2005) 5:517–29.
   Google Scholar
• RAO M, SOCKANATHAN S: Molecular mechanisms of RNAi: implications for development and disease. Birth Defects Res. C. Embryo Today (2005) 1:28–42.
   Google Scholar
• LECELLIER CH, DUNOVER P, ARAR K et al.: A cellular microRNA mediates antiviral defense in human cells. Science (2005) 5721:557–560.
   Google Scholar
• ••One of the earliest descriptions of theantiretroviral role of small RNAs.
   Google Scholar
• TOMARI Y, ZAMORE PD: MicroRNA biogenesis: drosha can't cut it without a partner. Cuff. Biol. (2005) 2:R61–R64.
   Google Scholar
• HULL R, HARPER G, LOCKHART B: Viral sequences integrated into plant genomes. Trends Plant Sci. (2000) 5:362–265.
   PubMed Web of Science ®Google Scholar
• JENSEN S, GASSAMA MP, DRAMARD X et al.: Regulation of /-transposon activity in Drosophila: evidence for cosuppression of nonhomologous transgenes and possible role of ancestral /-related pericentromeric elements. Genetics (2002) 162:1197–1209.
   PubMed Web of Science ®Google Scholar
• VOINNET O: Induction and suppression of RNA silencing: insights from viral infections. Nat. Rev. Genet. (2005) 3:206–220.
   Google Scholar
• DUNOYER P, LECELLIER CH, PARIZOTTO EA et al.: Probing the microRNA and small interfering RNA pathways with virus-encoded suppressors of RNA silencing. Plant Cell (2004) 5:1235–1250.
   Google Scholar
• DING SW, LI H, LU R et ell.: RNA silencing: a conserved antiviral immunity of plants and animals. Virus Res. (2004) 102:109–115.
   Google Scholar
• KASSCHAU KD, XIE Z, ALLEN E et al.:P1/HC-Pro, a viral suppressor of RNA silencing, interferes with Arabidopsis development and miRNA unction. Dev. Cell (2003) 2:205–217.
   Google Scholar
• BAGASAR O: HIV and Molecular Immunity: Prospect for AIDS Vaccine. Eaton Publishing, Natic, MA, USA (1999).
   Google Scholar
• ••A surprising and detailed account ofsiRNAs and miRNAs and their protective roles in host defence.
   Google Scholar
• BAGASRA O, WHITTLE P, POMERANTZ R: The role of CD8+ lymphocytes on unstimulated peripheral blood lymphocytes to infection with HIV-1. ImmunoL Lett. (1993) 35:83–92.
   PubMed Web of Science ®Google Scholar
• •Probably the very first time the concept of antiretroviral endogenous immunity was presented.
   Google Scholar
• COFFIN JM, HUGHES SH, VARMUS HE: Retroviruses. Coffin JM, Hughes SH, Varmus HE (Eds), Cold Spring Harbor Press, Cold Spring Harbor, New York, USA (1997).
   Google Scholar
• COCCHI F, DEVICO AL, GARZINO-DEMO A et ell.: as the major HIV-1 and MIP-la identification of RANTES, MIP-1 suppressive factors produced by CD8+ T cells. Science (1995) 270:1811–1815.
   Google Scholar
• •A first account of the co-receptors that are supposedly required for HIV-1 entry into the target cells.
   Google Scholar
• CHOE H, FARZAN M, SUN Yet al.: The0-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell (1996) 85:1135–1148.
   Google Scholar
• ALKHATIB G, COMBADIERE C, BRODER CC et aL: CC CKR5: a RANTES, MIP-lalpha, MIP-lbeta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science (1996) 272: 1955-1958.
   Google Scholar
• SAMSON M, LIBERT F, DORANZ BJ et al.: Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of CCR-5 chemokine receptor gene. Nature (1996) 382:722–725.
   PubMed Web of Science ®Google Scholar
• GOFF SP: Genetic control of retrovirus susceptibility in mammalian cells. Annu. Rev. Genet. (2004) 38:61–85.
   PubMed Web of Science ®Google Scholar
• •An excellent review.
   Google Scholar
• FASSATI S, GOFF SP: Characterization of intracellular reverse transcription complexes of Moloney murine leukemia virus. J. Wrol. (1999) 73:8919–8925.
   Google Scholar
• GILBOA E, MITRA SW, GOFF S, BALTIMORE D: A detailed model of reverse transcription and tests of crucial aspects. Cell (1979) 18:93–100.
   PubMed Web of Science ®Google Scholar
• POMMIER Y, JOHNSON AA, MARCHAND C: Integrase inhibitors to treat HIV/AIDS. Nat. Rev. Drug Discov. (2005) 3:236–248.
   Google Scholar
• BUKRINSKY MI, SHAROVA N, DEMPSEY MP et al.: Active nuclear import of human immunodeficiency virus Type 1 preintegration complexes. Proc. NatL Acad. Sci. USA (1992) 89:6580–6584.
   PubMed Web of Science ®Google Scholar
• LEWIS P, HENSEL M, EMERMAN M: Human immunodeficiency virus infection of cells arrested in the cell cycle. EMBO J. (1992) 11:3053–3058.
   PubMed Web of Science ®Google Scholar
• LASSEN K, HAN Y, ZHOU Y et al.: The multifactorial nature of HIV-1 latency. Trends MoL Med. (2004) 11:525–531.
   Google Scholar
• OAKES JW, BAGASRA O, DUAN Let al.: Association of alterations in NF-kappa B moieties with HIV Type 1 proviral latency in certain monocytic cells. AIDS Res. Hum. Retroviruses (1994) 10:1213–1219.
   Google Scholar
• POMERANTZ RJ, BAGASRA O, BALTIMORE D: Cellular latency of human immunodeficiency virus Type 1. Curr. Opin. ImmunoL (1992) 4:475–480.
   PubMed Web of Science ®Google Scholar
• VAN LINT C, QUIVY V, DEMONTE D et al.: Molecular mechanisms involved in HIV-1 transcriptional latency and reactivation: implications for the development of therapeutic strategies. Bull. Mem. Acad. R. Med. Belg. (2004) 159:176–189.
   PubMedGoogle Scholar
• HAMER DH: Can HIV be cured? Mechanisms of HIV persistence and strategies to combat it. Curr. HIV Res. (2004) 2:99–111.
   PubMed Web of Science ®Google Scholar
• VARMUS HE, LEVINSON WE, BISHOP JM et al.: Extent of transcription by the RNA-dependent DNA polymerase of Rous sarcoma virus. Nat. New Biol. (1971) 35:19–21.
   Google Scholar
• ••A first and a revolutionary concept ofreverse transcription. A paradigm shift in our understanding of molecular biology.
   Google Scholar
• BALTIMORE D: RNA-dependent DNA polymerase in virions of RNA tumour viruses. Nature (1970) 5252:1209–1211.
   Google Scholar
• WESTERHOUT EM, OOMS M, VINK M et al.: HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome. Nucleic Acids Res. (2005) 33:796–804.
   PubMed Web of Science ®Google Scholar
• BODEN D, PUSCH O, LEE F et al.: Human immunodeficiency virus Type 1 escape from RNA interference. J. ViroL (2003) 77:11531–11535.
   PubMed Web of Science ®Google Scholar
• BAGASRA O, KHALILI K, SESHAMMA T et al: TAR-independent replication of human immunodeficiency virus Type 1 in glial cells. J. Wrol. (1992) 12:7522–7528.
   Google Scholar
• CULLEN BR, GREENE WC: Regulatory pathways governing HIV-1 replication. Cell (1989) 58:423–426.
   PubMed Web of Science ®Google Scholar
• SHARP PA, MARCINIAK RA: HIV Tar: an RNA enhancer? Cell (1989) 59:229–230.
   PubMed Web of Science ®Google Scholar
• GATIGNOL A, BUCKLER-WHITE A, BERKHOUT Bet al.: Characterization of a human TAR RNA-binding protein that activates the HIV-1 LTR. Science (1991) 251:1597–1599.
   Google Scholar
• ZEICHNER SL, KIM JY, ALWINE JC et al.: Linker-scanning mutational analysis of the transcriptional activity of the human immunodeficiency virus Type 1 long terminal repeat. J. Wrol. (1991) 65:2436–2444.
   Google Scholar
• GARCIA JA, OU SH, WU F et al: Cloning and chromosomal mapping of a human immunodeficiency virus 1 'TATA' element modulatory factor. Proc. Natl Acad. Sci. USA (1992) 89:9372–9376.
   PubMed Web of Science ®Google Scholar
• ROSS EK: Contribution of NF-KB and Spl binding motifs to the replicative capacity of human immunodeficiency virus Type 1: distinct patterns of viral growth are determined by T-cell types. J. ViroL (1991) 65:350–358.
   PubMedGoogle Scholar
• CULLEN BR: Nuclear mRNA export: insights from virology. Trends Biochem. Sci. (2003) 28:419–424.
   PubMed Web of Science ®Google Scholar
• FEINBERG MB, BALTIMORE D, FRANKEL AD: The role of tat in the human immunodeficiency virus life cycle indicate a primary effect n transcriptional elongation. Proc. Nail. Acad. Sci. USA (1991) 88:4045–4049.
   PubMed Web of Science ®Google Scholar
• COCHRON k Controlling HIV-1 Rev function. Curr. Drug Targets Immune Endocr. Metabol Disord. (2004) 4:287–295.
   PubMedGoogle Scholar
• HOUT DR, MULCAHY ER, PACYNIAK E et al.: Vpu: a multifunctional protein that enhances the pathogenesis of human immunodeficiency virus Type 1. Curr. HIV Res. (2004) 2:255–270.
   PubMed Web of Science ®Google Scholar
• BAGASRA O, WRIGHT SD, SESHAMMA T et al: CD14 is involved with the control of human immunodeficiency virus Type 1 (HIV-1) expression in latently-infected cells. Proc. Natl Acad. Sci. USA (1992) 89:6285–6289.
   PubMed Web of Science ®Google Scholar
• BAGASRA O, POMERANTZ RJ: The roleof CD8-positive lymphocytes in the control of HIV-1 infection of peripheral blood mononuclear cells. Immunol Lett. (1993) 2:83–92.
   Google Scholar
• SESHAMMA T, BAGASRA O, TRONO D et al.: Blocked early-stage latency in the peripheral blood cells of certain individuals infected with human immunodeficiency virus Type 1. Proc. Nail. Acad. Sci. USA (1992) 22:10663–10667.
   Google Scholar
• BAGASRA O, AMJAD M: Protection against retroviruses are owing to a different form of immunity. An RNA-based molecular immunity hypothesis. Appl Immunohistochem. Md. Morphol (2000) 2:133–146.
   Google Scholar
• ONDOA P, KESTENS L, DAVIS D et al: Longitudinal comparison of virus load parameters and CD8 T-cell suppressive capacity in two SIVcpz-infected chimpanzees. J. Med. Primatol. (2001) 30:243–253.
   PubMed Web of Science ®Google Scholar
• APETREI C, ROBERTSON DL, MERX PA: The history of SIVS and AIDS: epidemiology, phylogeny and biology of isolates from naturally SIV infected non-human primates (NHP) in Africa. Front. Biosci. (2004) 9:225–254.
   PubMed Web of Science ®Google Scholar
• •An excellent review of lentiviruses, their origin and evolution.
   Google Scholar
• SALEMI M, DE OLIVEIRA T, COURGNAUD Vet al: Mosaic genomes of the six major primate lentivirus lineages revealed by phylogenetic analyses. J. Wrol. (2003) 77:7202–7213.
   Google Scholar
• HULL R, HARPER G, LOCKHART B: Viral sequences integrated into plant genomes. Trends Plant Sci. (2000) 5:362–365.
   PubMed Web of Science ®Google Scholar
• JAKOWITSCH J, METTE MF, VAN DER WINDEN J et al: Integrated pararetroviral sequences define a unique class of dispersed repetitive DNA in plants. Proc. Natl Acad. Sci. USA (1999) 96:13241–13246.
   PubMed Web of Science ®Google Scholar
• OTTING N, DE GROOT NG, DOXIADIS GG et al.: Extensive Mhc-DQB variation in humans and non-human primate species. Immunogenetics (2002) 54:230–239.
   Google Scholar
• ROBERTSON DL, SHARP PM, MCCUTCHAN FE et al: Recombination in HIV-1. Nature (1995) 374:124–126.
   PubMed Web of Science ®Google Scholar
• GARBER DA. SILVESTRI G, FEINBERG MB: Prospects for an AIDS vaccine: three big questions, no easy answers. Lancet Infect. Dis. (2004) 7:397–413.
   Google Scholar
• WADHWA R, KAUL SC, MIYAGISHI M et al: Vectors for RNA interference. Curr. Opin. Mol Ther. (2004) 4:367–372.
   Google Scholar
• PFEFFER S, SEWER A, LAGOS-QUINTANA M et al: Identification of microRNAs of the herpesvirus family. Nat. Methods (2005) 2:269–276.
   PubMed Web of Science ®Google Scholar
• CAI X, LU S, ZHANG Z et al.: Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells. Proc. Natl Acad. Sci. USA (2005) 102:5570–5575.
   PubMed Web of Science ®Google Scholar
• OMOTO S, ITO M, TSUTSUMI Y et al: HIV-1 nef suppression by virally encoded microRNA. Retrovirology (2004) 1:44.
   PubMedGoogle Scholar
• BENNASSER Y, LE SY, YEUNG ML et al: HIV-1 encoded candidate micro-RNAs and their cellular targets. Retrovirology (2004) 1:43.
   PubMedGoogle Scholar
• KREK A, GRUN D, POY MN et al: Combinatorial microRNA target predictions. Nat. Genet. (2005) 37:495–500.
   PubMed Web of Science ®Google Scholar
• SCHAACK J: Induction and inhibition of innate inflammatory responses by adenovirus early region proteins. Viral Immunol (2005) 1:79–88.
   Google Scholar
• MURUVE DA: The innate immune response to adenovirus vectors. Hum. Gene Ther. (2004) 12:1157–1166.
   Google Scholar
• CHECK E: Sanctions agreed over teenager's gene-therapy death. Nature (2005) 433:674.
   PubMed Web of Science ®Google Scholar
• KAISER J: Gene therapy. Panel urges limits on X-SCID trials. Science (2005) 307:1544–1545.
   Google Scholar
• YI Y, HAHM SH, LEE KH: Retroviral gene therapy: safety issues and possible solutions. Curr. Gene Ther. (2005) 1:25–35.
   Google Scholar
• TOMANIN R, SCARPA M: Why do we need new gene therapy viral vectors? Characteristics, limitations and future perspectives of viral vector transduction. Curr. Gene Ther. (2004) 4:357–372.
   PubMed Web of Science ®Google Scholar
• MUKHTAR M, PARVEEN Z, BAGASRA 0: Human gene therapy. Dreams to realization. Methods MoL Biol. (1997) 63:415–437.
   PubMedGoogle Scholar
• VENTURA A, MEISSNER A, DILLON CP et al.: Cre-lox-regulated conditional RNA interference from transgenes. Proc. Natl Acad. Sci. USA (2004) 101:10380-10385. Website
   Google Scholar
• http://www.unaids.org/wad 192004/ report.html UNAIDS website (2004).
   Google Scholar